Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection
Author:
Affiliation:
1. Departments of Microbiology and Medicine, Columbia University, New York, New York, and Institute for Research in Biomedicine, Bellinzona, Switzerland
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Link
https://journals.asm.org/doi/pdf/10.1128/JVI.01519-06
Reference98 articles.
1. Balzarini, J., E. De Clercq, and K. Uberla. 1997. SIV/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaques. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.15:1-4.
2. Disruption of Human TRIM5α Antiviral Activity by Nonhuman Primate Orthologues
3. Berthoux, L., S. Sebastian, E. Sokolskaja, and J. Luban. 2005. Cyclophilin A is required for TRIM5α-mediated resistance to HIV-1 in Old World monkey cells. Proc. Natl. Acad. Sci. USA102:14849-14853.
4. Lv1 Inhibition of Human Immunodeficiency Virus Type 1 Is Counteracted by Factors That Stimulate Synthesis or Nuclear Translocation of Viral cDNA
5. Besnier, C., Y. Takeuchi, and G. Towers. 2002. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA99:11920-11925.
Cited by 129 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rabies virus uniquely reprograms the transcriptome of human monocyte-derived macrophages;Frontiers in Cellular and Infection Microbiology;2023-01-31
2. HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules;Retrovirology;2021-10-26
3. Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2;Cell Reports;2021-04
4. Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2;2020-06-19
5. Cyclophilin A protects HIV-1 from restriction by human TRIM5α;Nature Microbiology;2019-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3